57598-34-2 Usage
General Description
N-BOC-N-Methyl-3-bromoaniline is a chemical compound with the molecular formula C13H18BrNO2. It is a derivative of aniline and contains a bromine atom as well as a BOC (tert-butoxycarbonyl) protecting group and a methyl group. N-BOC-N-Methyl-3-broMoaniline is commonly used as a reagent in organic synthesis and pharmaceutical research for the introduction of the N-BOC-N-Methyl-3-bromoaniline group into various molecules. It is a versatile building block for the creation of complex organic compounds and is often utilized in the development of new drugs and materials. Additionally, it is important to handle this compound with caution, as it is considered hazardous and should only be used by trained professionals with appropriate safety equipment and procedures.
Check Digit Verification of cas no
The CAS Registry Mumber 57598-34-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,5,9 and 8 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 57598-34:
(7*5)+(6*7)+(5*5)+(4*9)+(3*8)+(2*3)+(1*4)=172
172 % 10 = 2
So 57598-34-2 is a valid CAS Registry Number.
57598-34-2Relevant articles and documents
DIACYLGLYCEROL KINASE MODULATING COMPOUNDS
-
Paragraph 1833, (2021/07/02)
The present disclosure provides diacylglycerol kinase modulating compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors, and viral infections, such as HIV or hepatitis B virus infection. The compounds can be used alone or in combination with other agents.
MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS
-
, (2019/06/19)
The present disclosure provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
NOVEL BIAROMATIC COMPOUNDS WHICH ACTIVATE PPARγ-TYPE RECEPTORS, THEIR PROCESS OF PREPARATION AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
-
, (2008/06/13)
The invention relates to novel biaromatic compounds which correspond to the following general formula (I) and to their method of preparation and to their use in pharmaceutical compositions intended for use in human or veterinary medicine, in particular in
